Dov Pharmaceutical, Inc - DOVP Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Dov Pharmaceutical, Inc - DOVP

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: michael_f_murphy who started this subject	4/12/2002 3:19:34 AM
From: michael_f_murphy	of 172

OUR PRODUCT PIPELINE The following table summarizes our product candidates currently in clinical trials and preclinical development: PRODUCT INDICATION(S) STATUS MARKETING RIGHTS --------------------- --------------------------------- ----------------- ------------------------- NBI-34060 Insomnia Phase III Neurocrine Ocinaplon Generalized Anxiety Disorder Phase II DOV Bermuda Bicifadine Pain Phase II DOV Bermuda DOV 216,303 Depression Phase I DOV DOV Diltiazem Angina and Hypertension Phase I, DOV/Biovail Phase III planned DOV 21,947 Depression Preclinical DOV DOV 22,047 Panic Disorder Preclinical DOV DOV 102,677 Attention Deficit Disorder and Preclinical DOV Parkinson's Disease DOV 102,177 Stress Incontinence Preclinical DOV For an explanation of the terms Preclinical, Phase I, Phase II and Phase III, please refer to the text in subheading "Government Regulation" in this "Business" section.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext